Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Neuralgia 2Neoplasms 2Lung Neoplasms 2Leiomyoma 2Sexual Dysfunction, Physiological 1Scleroderma, Localized 1Pneumonia 1Pain 1Neuropathy, Painful 1Neurofibromatoses 1Neurodermatitis 1Neoplasms, Cystic, Mucinous, and Serous 1Mastodynia 1Lymphoma, Follicular 1Lichen Planus 1Leukemia-Lymphoma 1Kidney Neoplasms 1Keratoacanthoma 1Keloid 1Ileus 1Hydrocephalus 1Hordeolum 1Headache 1Granuloma Annulare 1Eyelid Neoplasms 1Epilepsy 1Dermoid Cyst 1Colorectal Neoplasms 1Cold Hypersensitivity 1

Interventions

Lidocaine 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cold Hypersensitivity × Lidocaine × Clear all
NCT03254394 2022-03-09

Lidocaine for Oxaliplatin-induced Neuropathy

Washington University School of Medicine

Phase 1/2 Completed
26 enrolled 10 charts
Gastrointestinal

Neuropathy, Painful, Cold Hypersensitivity, Neuralgia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡